NHSN Reporting for Critical Access Hospitals

Slides:



Advertisements
Similar presentations
HAI Program Update Meredith Kanago, MSPH TDH Statewide CEDEP Meeting 30 April 2014.
Advertisements

Developing a Framework for Estimation of Healthcare-Associated Infection Burden at the National and State Level Matthew Wise, MPH, PhD Epidemiologist,
Antimicrobial Stewardship: an HAI response activity in Connecticut Richard Melchreit, MD HAI Program Coordinator.
Our vision is 'healthy Kansans living in safe and sustainable environments'. The state belongs to all of us - "Kansas Don't Spoil It"
Abstract Results continued Reference 1 McDonald LC, Coignard B, Dubberke E, et al. Recommendations for Surveillance of Clostridium difficile-Associated.
Introduction to the National Healthcare Safety Network (NHSN) Richard Rodriguez, MPH Connecticut Department of Public Health 4/9/2014 Thank you to CDC.
NHSN CASE STUDIES or… Russ’s title NHSN Jeopardy Allison Gibson Murad, MPH aka Allie “Trebek” NHSN Epidemiologist Surveillance for Healthcare-Associated.
James Marx, PhD, RN, CIC Broad Street Solutions October 2014.
Washington State Hospital Association Partnership for Patients Safe Table Reducing Hospital Acquired Infections July 31, 2013 Amber Theel, Director Patient.
C. difficile Lab ID Reporting in NHSN Stanley Ostrawski RN, MS, MT(ASCP), CIC Infection Preventionist Consultant.
Don Wright, MD, MPH Deputy Assistant Secretary for Healthcare Quality Office of Healthcare Quality Office of the Assistant Secretary for Health U.S. Department.
Tennessee Center for Patient Safety Data Reporting.
Welcome to the GHA InfectionPrevention Power Hour December 18, 2014.
CDC Winnable Battles: Preventing Healthcare-Associated Infections (HAIs) National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare.
Burton Garten Indiana State Department of Health.
Healthcare-Associated Infection (HAI) Prevention
Healthcare-associated Infections and Antibiotic Resistance
Objectives After this session, the attendee should be able to:
Dexanne B. Clohan, MD SVP & Chief Medical Officer HealthSouth November 14, 2014 IRF Quality Measurement: A Physiatrist’s View.
Presentation to: Georgia Hospital Association Presented by: Matthew Crist, MD, MPH Date: October 31, 2012 The Path to National Healthcare Surveillance.
U.S. Dept of Health & Human Serviceswww.hhs.gov/ash/initiatives/hai/ Office of the Assistant Secretary for Healthwww.hhs.gov/ash/ohq/
MQF HAI Subcommittee: HAI Plan Update June 24, 2013 Peg Shore, MT, MSPH, Ph.D., CIC HAI Prevention Coordinator.
NHSN Data Submission Requirements 2013 Health Care Excel Cathie Pritchard LPN, RHIT Quality Data Reporting Technologist October 12, 2012.
Georgia Hospital Engagement Network HAI Affinity Group July 9 TH, :00 – 11:30 AM.
Long Term Care CDI/MDRO Prevention Collaborative: Connecticut Program Update Richard Melchreit, MD HAI Program Coordinator.
Katherine Allen-Bridson, RN, BSN, MScPH, CIC, Centers for Disease Control and Prevention National Center for Emerging and Zoonotic Infectious Diseases.
CDI prevention: A call to action for nursing homes
NHSN Reporting for Laboratory-identified Clostridium difficile Infection (CDI) and Methicillin-resistant Staphylococcus aureus (MRSA) (Bacteremia) Presentation.
Public Health Surveillance
Indiana Healthcare Associated Infection Initiative Kickoff.
Using and Sharing Findings from Surveillance: Rates, Ratios Proportions, Data Display & OUTBREAKS Russ Olmsted, MPH, CIC
Mary Andrus, BA, RN, CIC Division of Healthcare Quality Promotion
Background In July 2009, New York State (NYS) began using the National Healthcare Safety Network (NHSN) LabID Event module to report facility-wide Clostridium.
Illinois Healthcare-Associated Infections (HAI) Plan Mary Fornek January 21, 2010 Metropolitan Chicago Healthcare Council.
Cohort 1A-C Coaching Call October 1, 2014 Facilitators: Lisa Carhuff Kathy McGowan Joyce Reid.
Overview Linkage: Providing Safe and Effective care, Coordinating Care, & The Joint Commission National Patient Safety Goal #8, Reconciling Medications.
A RIDDLE WRAPPED IN A MYSTERY INSIDE AN ENIGMA: NHSN SURVEILLANCE DEFINITIONS MSIPC Fall 2015 Interactive Breakout Session Allison Murad, MPH Michigan.
Cohort Coaching Call “Cohort 9” October 15, 2014 Coaches: Tracy Rutland Jean Allred Jan Ratterree Lynne Hall.
Chapter Legislative Representatives Government Affairs Update April 2014.
NHSN 101 Nancy Wilde HAI Coordinator Iowa Department of Public Health.
Welcome to the GHA Infection Prevention Power Hour September 25, 2013.
Purposes of NHSN Participation in the NHSN reflects the individual facility’s need for high quality and timely data on adverse events and adherence to.
CDC Winnable Battles: Preventing Healthcare-Associated Infections (HAIs) National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare.
Standard Vocabulary Implementation Experience from CDC Partners and Programs PHIN Conference August 25, :30 a.m. – 12 noon.
Yousef I. Aljeesh, PhD, RN Said Abusalem, PhD, RN Naeem Alkariri, MSN, RN John A. Myers, PhD, MSPH Fawwaz Alaloul, PhD, RN Staff Developed IP Program Increases.
Tennessee Partnership for Patients Tennessee Department of Health (TDH) Perspective Brynn E. Berger, MPH, CIC Epidemiologist, TDH TCPS Regional Meetings.
The AHRQ Safety Program for Improving Antibiotic Use
Quality Measurement A Changing Landscape
Kelley Garner, MPH MLS(ASCP)CM
Horizon Lab™ Optimizing Clinical Performance to Increase Patient and Lab Safety
Impact of State Reporting Laws on Central Line– Associated Bloodstream Infection Rates in U.S. Adult Intensive Care Units Hangsheng Liu, Carolyn T. A.
Michelle Charles MSN, RN Karen Vallejo MSN, RN, CIC
CMS HAI Reporting Requirements via NHSN
CDI Collaborative Susan Irving, RN, CIC, MPH
Engaging a Microsystem to Reduce 30-Day Readmissions on an Acute Care Unit Erin Johnson, MSN, RN, Sara Stetz, MSN, RN.
Introduction to CAUTI and CLABSI Initiatives
Keeping the Glowing Going: Preview of Upcoming HAI Activities in NM
Robin Nettleton MSN RN St. Luke’s Elmore, Mountain Home
Housekeeping.
APIC Chapter 13 Journal Club
Changes to 10A NCAC 41A May 5, 2018.
CNISP & CIHI MRSA infection rate comparison Preliminary results
ECDC point prevalence survey (PPS)
Information for Action HCAI Surveillance Data: Laboratory data 15th July 2015 Mari Morgan WHAIP Surveillance.
Background and Context
C. Difficile Surveillance Quality Improvement Initiative Baystate Health System Anne Zawacki RN MPH CIC.
National Center for Emerging and Zoonotic Infectious Diseases
Quality Management System
C. diff Testing Stewardship
February 2017 Presented By: Shanelle Van Dyke
Presentation transcript:

NHSN Reporting for Critical Access Hospitals Allison Murad, MPH Surveillance for Healthcare-Associated and Resistant Pathogens (SHARP) Unit Michigan Department of Health and Human Services (MDHHS)

Why NHSN? The “Gold Standard” for HAI Reporting and Surveillance Clinical vs. Surveillance Definitions: Clinical: Individualized Used for making therapeutic decisions Surveillance Population-based Must be applied uniformly and consistently

The Essentials of Infection Surveillance Know protocol/criteria Consistently apply the criteria Report events meeting criteria; exclude those that don’t Failure to do so: Breach of NHSN Rules of Behavior Decreased usefulness of national comparative data Unfair comparisons between facilities Possible validation discrepancies Potential impact of CMS Inpatient Quality Reporting score & facility reimbursement

Components of NHSN

Not Enrolled in NHSN? Start here: https://www.cdc.gov/nhsn/acute-care-hospital/enroll.html

Already Enrolled in NHSN for HCP? If you’ve enrolled your facility in NHSN in order to report Healthcare Personnel Influenza Vaccination Data, you can activate the Patient Safety Component by going to: Facility – Add/Edit Component

Add additional users to your facility! Users – Add

Patient Safety Component Device-Associated Module CLABSI CLIP CAUTI VAE VAP Procedure-Associated Module SSI Antimicrobial Use and Resistance Module (AUR) Multidrug-Resistant Organism and Clostridium difficile Infection (MDRO/CDI) Module MRSA LabID CDI LabID

MDRO/CDI Reporting “The NHSN MDRO/CDI Module offers a means for facilities to meet criteria and metrics that are outlined in several organizational guidelines to control and measure the spread of MDROs and CDI within their healthcare system.” “As outlined in the HICPAC guideline, these MDRO and C.difficile pathogens may require specialized monitoring to evaluate if intensified infection control efforts are required to reduce the occurrence of these organisms and related infections. The goal of this module is to provide a mechanism for facilities to report and analyze these data that will inform infection prevention professionals of the impact of targeted prevention efforts.”

LabID Reporting LabID Event reporting is based strictly on laboratory testing data without clinical evaluation of the patient, allowing for a much less labor intensive method to track C. difficile and MDROs, such as MRSA. Advantages of LabID Event Reporting Objective laboratory-based metrics Estimate infection burden Estimate exposure burden Assess need for and effectiveness of interventions Standardized case definitions Increased comparability between settings

Categorization of CDI LabID Events Incident: Event from a specimen obtained >56 days (8 weeks) after the most recent CDI LabID Event (or with no previous CDI LabID Event documented) Day 1 = date of first specimen collection Recurrent: Event from a specimen obtained >14 days (2 weeks) and ≤ 56 days (8 weeks) after the most recent CDI LabID Event Duplicate: Event from the same patient AND location, following a previous lab result within the past two weeks (14 days), even across calendar months and readmissions to the same facility. Duplicate events will prompt a pop-up message that will not allow you to enter

Categorization of CDI LabID Events Healthcare-Onset (HO): Positive toxin tests collected >3 days after admission to the facility (i.e., on or after hospital day 4) Community-Onset (CO): LabID Event collected in an outpatient location or an inpatient location ≤3 days after admission to the facility (i.e., days 1, 2, or 3 of admission). Community-Onset Healthcare Facility-Associated (CO-HCFA): CO LabID Event collected from a patient who was discharged from the facility ≤4 weeks prior to current date of stool specimen collection. Data from outpatient locations (e.g., outpatient encounters) are not included in this definition.

Best part of categorization? NHSN categorizes for you! Running and exporting data will show the rates and ratios of each categorized event type facility-wide

What can you do with the data?

MDHHS Feedback Reports

National NHSN Use As of March 2017:

CMS Reporting Requirements

MDHHS SHARP Unit Validation Activities Statewide NHSN User Group Webinars, Next Call: Wednesday, June 28th at 10am ICAR Assessments/Infection Control Consulting: Noreen Mollon, MollonN@michigan.gov CRE Surveillance and Prevention Initiative: Brenda Brennan, BrennanB@michigan.gov Antimicrobial Resistance: Sara McNamara, McNamaraS5@michigan.gov

Thank you! Allison Murad, MPH Surveillance for Healthcare-Associated and Resistant Pathogens (SHARP) Unit, MDHHS murada@michigan.gov www.michigan.gov/hai